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ABSTRACT To exert their effects, glucocorticoid receptor
complexes interact selectively with DNA sequences known as
glucocorticoid regulatory elements. We have studied the inter-
action between human glucocorticoid receptors and mouse
mammary tumor virus (MMTV) DNA by means of a procedure
that permits analysis after immobilization of the receptor on
nitrocellulose. Proteins from crude cytosolic or nuclear extracts
were electrophoresed on NaDodSO4/PAGE gels, soaked in a
urea buffer to remove NaDodSO4, transferred to nitrocellulose,
and probed with nick-translated MMTV [32P]DNA in a 5%
nonfat dry milk buffer, which minimizes nonselective DNA-
protein interactions. We present evidence that MMTV
[32P]DNA interacts selectively with the glucocorticoid receptor.
These data include (I) comigration of [3H]dexamethasone
mesylate-labeled band and bound MMTV [32P]DNA on gel
electrophoresis systems; (it) localization of DNA-binding activ-
ity in the cytosol of cells incubated with steroid at 0C and in
the nucleus and cytosol of cells incubated at 37°C; (iii) binding
oftheMMTVDNA to highly purified receptor; and (iv) absence
of MMTV DNA binding activity in extracts from cells whose
receptor has been down-regulated. Furthermore, glucocorti-
coid receptors analyzed under these conditions exhibit selective
binding to DNA fragments that contain glucocorticoid regula-
tory elements.
Glucocorticoids exert their physiological effects on target
tissues by binding to specific receptor proteins that are
present in glucocorticoid-responsive cells. Hormone-recep-
tor complexes translocate to the nucleus and bind to specific
DNA regions upstream from or within the regulated genes
(1-4). The sequences to which the glucocorticoid receptors
bind are known as glucocorticoid regulatory elements
(GREs) and are typified by a region of the long terminal
repeat (LTR) in the DNA of the glucocorticoid-regulated
mouse mammary tumor virus (MMTV) (5-9). Recombinant
DNA transfection experiments have shown that this GRE can
confer hormone responsiveness upon linked heterologous
genes (10, 11).
Despite this progress, a great many unanswered questions
remain concerning steroid-receptor structure and interac-
tions with DNA. We report the development of a technique
that permits simultaneous analysis of receptor structure and
receptor-DNA interactions. Our methodology combines the
use of affinity-labeled receptors (12, 13), protein blotting, and
selective DNA binding.
Previous studies of specific DNA-protein interactions,
which include nitrocellulose filter binding assays (14), DNase
I hypersensitivity (15), and cleavage inhibition patterns (4),
are often unable to identify the interactive protein and
consequently require its extensive purification. Bowen et al.
(16) developed a procedure for detecting DNA-protein in-
teractions after separation of proteins on NaDodSO4 gels and
blotting onto nitrocellulose. We report here that, with mod-
ifications including the use of "blotto binding buffer" (17),
selective glucocorticoid receptor-DNA interactions can be
observed under these conditions.
MATERIALS AND METHODS
Preparation of Glucocorticoid Receptor Extract. HeLa S3
cells were grown in suspension at 37°C in Joklik's minimal
essential medium (JMEM) containing 2 mM glutamine, 75
units of penicillin G per ml, 50 units of streptomycin sulfate
per ml, and 3.0% of a 1:1 (vol/vol) mixture of fetal calf serum
and calf serum. Cells were harvested, washed in cold unsup-
plemented JMEM, and resuspended to a final cell density of
2-4 x 107 cells per ml. Approximately 2-4 x 108 cells were
incubated with 10-20 nM [3H]dexamethasone mesylate (New
England Nuclear, 48.9 Ci/mmol; 1 Ci = 37 GBq) for 2 hr at
0°C with gentle agitation. Then the cells were pelleted and
resuspended in an equal volume of ice-cold 10 mM Tris HCl,
pH 8.3/1 mM EDTA and homogenized by using a prechilled
Tekmar Ultra Turrax homogenizer (Tekmar, Cincinnati,
OH). The homogenate was immediately centrifuged at
100,000 x g for 1 hr at 0°C. The supernatant obtained at high
speed (cytosol) was collected and added to the pellet from an
equal volume of dextran-coated charcoal (1% activated
charcoal in 0.1% dextran/1.5 mM MgCl2) and incubated on
ice for 5 min. The cytosol/charcoal suspension was then
centrifuged at 7000 x g for 10 min at 0°C, and the supernatant
was collected.
Blotting Procedure. Aliquots of cytosol either were heat-
activated by warming to 27°C for 30 min or were held on ice,
then mixed 1:1 (vol/vol) with Fairbanks sample buffer (2%
NaDodSO4/20 mM Tris/2 mM Na2EDTA/10% sucrose/20
,Ag of pyronin Y tracking dye per ml at pH 7.5), and heated
at 100°C for 5 min. Aliquots (2 ml) of the denatured cytosols
were electrophoresed on preparative slab gels consisting of a
3.0% acrylamide stacking gel and a 7.5% acrylamide sepa-
rating gel (18). After electrophoresis, gels were incubated for
two 1-hr washes in 200 ml of renaturation buffer (50 mM
NaCl/10 mM Tris HCl, pH 7.0/20 mM EDTA/0.1 mM
dithiothreitol/4 M urea) (16) with gentle agitation. Although
the extent of renaturation is not known, these washes in 4 M
urea removed NaDodSO4 from the proteins and permitted
functional recognition of the DNA binding domain. The
proteins were electrophoretically transferred onto BA85
nitrocellulose sheets (19). Strips were cut from the nitrocel-
lulose filters, placed into heat-sealable plastic bags containing
Abbreviations: MMTV, mouse mammary tumor virus; GRE, gluco-
corticoid regulatory element; LTR, long terminal repeat.
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binding buffer (5% nonfat dry milk in 50 mM NaCl/10 mM
Tris HCl, pH 7.4/1 mM EDTA) and pretreated for 2 hr with
gentle agitation to block nonspecific DNA binding. The
preincubation buffer was then replaced with 5 ml of binding
buffer containing 6 x 106 cpm of [32P]DNA per ml, and the
filters were incubated at room temperature for 3 hr with
gentle agitation. After DNA binding, the filter strips were
washed for four 30-min washes in 50-100 ml of binding buffer,
rinsed briefly in STE buffer (100 mM NaCl, 10 mM Tris HCl,
pH 7.6/1 mM EDTA), and air-dried.
Two-Dimensional Gel Analysis. Samples of cytosol contain-
ing steroid receptor complexes were mixed 1:1 with lysis
buffer (9.5 M urea/2% Nonidet P-40/1.6% ampholytes of pI
6-8/0.4% ampholytes of pI 3-10/2% NaDodSO4) and stored
at -70'C until use. Tube gels (115 x 3 mm) consisting of 10
M urea, 3.69% acrylamide/0.21% methylene bisacrylamide,
2% Nonidet P-40, 4% ampholytes of pI 6-8, and 1%
ampholytes of pI 3-10 were prepared as described by
O'Farrell (20). After this treatment, samples that had been
thawed and sonicated were layered onto tube gels, followed
by the overlay solution and cathode buffer (20 mM NaOH),
and were subjected to isoelectric focusing for a total of
5000-9600 V-hr. Anode buffer consisted of 10 mM phospho-
ric acid. After electrophoresis, gels were extruded from the
tubes, placed in NaDodSO4/PAGE sample buffer (10%
glycerol/2.3% NaDodSO4/0.0625 M Tris'HCl, pH 6.8), fro-
zen in a dry-ice/ethanol bath, and stored at -70°C until use.
The tube gels were electrophoresed in the second dimension
on a 5-12% polyacrylamide gradient gel with a 3% acrylamide
stacking gel (45-60 mA per gel). Gels were then transferred
to nitrocellulose (19). The nitrocellulose was dried and
sprayed with EN3HANCE (New England Nuclear) to visu-
alize [3H]dexamethasone mesylate. Alternatively, gels were
incubated with renaturation buffer as stated under "Blotting
Procedure," transferred to nitrocellulose, and probed with
nick-translated MMTV DNA.
Isolation and Labeling of DNA Fragments. Plasmid DNA
was digested with the appropriate restriction enzymes, and
the resulting fragments were electrophoresed on 6.5% poly-
acrylamide gels containing 90 mM Tris borate and 2 mM
EDTA. Bands containing the desired DNA fragment were
excised from the gels. The DNA fragments used in these
experiments were: (i) the 325-base-pair (bp) Hae III-Hpa II
fragment derived from the LTR of MMTV DNA and (ii) the
312-bp Taq I E fragment of pBR322. The MMTV DNA used
contains the GRE that has been shown to confer hormone
responsiveness on heterologous genes (1-11). The gel slices
were crushed with a glass rod and extracted with 500 mM
NH4OAc/10mM Mg2(OAc)2/1 mM EDTA/0.1% NaDodSO4
(21) overnight in a 37°C shaker-incubator. Samples were then
centrifuged at 7000 x g for 10 min at room temperature. The
supernatants were collected, and the DNA fragments were
concentrated by precipitation with ethanol. The isolated
DNA fragments were labeled with [a-32P]dCTP by nick-
translation (22) (specific activity 108 cpm/,ug of DNA).
RESULTS
A modification of the DNA-protein blotting procedure de-
scribed by Bowen et al. (16) has been used to study the
interaction between glucocorticoid receptor and DNA. We
wished to determine if the DNA binding site of glucocorticoid
receptors retained the ability to interact selectively with the
GRE DNA after immobilization of the receptor on nitrocel-
lulose. Fig. 1 is a representative one-dimensional gel of
cytosolic proteins from HeLa S3 cells that had been incubated
for 2 hr at 0C with 20 nM [3H]dexamethasone mesylate. Fig.
1A shows the pattern of protein staining as seen by Coomas-
sie blue analysis; as expected with a cytosol preparation,













FIG. 1. NaDodSO4/PAGE analysis of steroid- and DNA-binding
activity of HeLa S3 cell protein. Cytosol from HeLa S3 cells
incubated with [3H]dexamethasone mesylate was prepared and
subjected to gel electrophoresis as indicated. Samples of the same
cytosol were run in replicate adjacent lanes, which were then subject
to Coomassie blue staining (A), affinity-labeling fluorography with
tritiated steroid (B), or MMTV [32P]DNA binding (C) as outlined. The
molecular weight markers myosin (M), phosphorylase b (PB), bovine
serum albumin (BSA), ovalbumin (OVAL), and chymotrypsinogen
(CHY) were electrophoresed in an adjacent lane and stained to
provide estimates of molecular size.
visualization of [3H]dexamethasone mesylate binding re-
vealed predominantly one protein band at 97 kDa (Fig. 1B).
This protein bound [3H]dexamethasone mesylate in a satu-
rable manner (data not shown) and comigrated with the
phosphorylase b marker (far left lane) as has been observed
(13). Fig. 1C is the autoradiograph of an adjacent lane of the
same gel, which was probed with MMTV [32P]DNA. Despite
the number of proteins present in the gel (as seen in Fig. LA),
only a limited number bound to the MMTV DNA, and one of
the major ones comigrated with the [3H]dexamethasone
mesylate-binding protein seen in Fig. 1B. Our goal was to
determine if the comigration of the receptor protein and the
MMTV DNA binding protein is fortuitous or is, in fact,
indicative of a selective interaction between them.
Previous studies (23) have shown that, in cells incubated at
0°C, the receptor is located only in the cytoplasmic compart-
ment, whereas it is found in both the cytoplasmic and nuclear
compartments of cells incubated at 37°C. If the 97-kDa
protein that binds the MMTV DNA in Fig. 1 is the gluco-
corticoid receptor, it would be expected to follow this same
pattern of subcellular distribution. HeLa S3 cells were incu-
bated with hormone for 2 hr either at 0°C or 37°C, and cytosol
and nuclear extracts (24) were prepared. The preparations
were processed for DNA binding analysis with MMTV
[32P]DNA. Lanes 1 and 2 of Fig. 2 represent cytosolic and
nuclear preparations, respectively, from cells that were
incubated with steroid at 0°C. Binding of MMTV [32P]DNA
was seen only in the cytosol to a protein band that migrated
at the approximate molecular weight of the phosphorylase b
marker. The fact that only a single band of bound MMTV
[32P]DNA was seen in this experiment, as compared to a
number of bands seen in Fig. 1, was due to improved binding
conditions, which included replacement of bovine serum
albumin, Ficoll, and polyvinylpyrrolidone with 5% nonfat dry
milk in the binding buffer. Binding conditions were the same
Biochemistry: Silva et al.
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FIG. 2. Subceliular distribution ofMMTV (2P]DNA binding activ-
ity in HeLa S3 cells. Two aliquots ofHeLa S3 cells (8 x 108 cells) were
incubated with 20nM [3H]dexamethasone mesylate for 2 hr at0C (lanes
1 and 2) or at 370C (lanes 3 and 4). After this, all samples were cooled
to 0C and divided into two equal aliquots. One sample from each group
of cells was used to prepare cytosol (CYTO), and one was used as a
source of nuclei (NUC), which were extracted with 0.4 M KCI (24).
Each cytosolic or desalted nuclear extract (100 IL) was then subjected
to electrophoresis and subsequent DNA-binding analysis (under iden-
tical conditions) as indicated. PB, phosphorylase b.
for each buffer used. Lanes 3 and 4 in Fig. 2 represent
cytosolic and nuclear preparations, respectively, from cells
incubated with steroid at 37TC. Under these conditions DNA
binding was seen in both cytosolic and in nuclear extracts.
This subcellular receptor distribution is consistent with the
biochemical data reported by several laboratories (23, 25, 26).
This correlation between the subcellular distribution of
MMTV [32P]DNA binding and the known subcellular distri-
bution ofthe steroid-receptor complex is one line ofevidence
suggesting that the DNA binding protein is the glucocorticoid
receptor. Close inspection of lane 2 in Fig. 2 reveals a high
molecular weight (>97 kDa) protein, and lane 4 shows a low
molecular weight (<45 kDa) protein, both binding to the
DNA. We frequently saw one or both of these proteins in
addition to the 97-kDa protein.
We next sought to analyze theDNA binding characteristics
of the protein in question by two-dimensional gel analysis.
We had previously analyzed the affinity-labeled glucocorti-
coid receptor on two-dimensional gels (13) and had detected
the presence of distinct isoelectric-point variants, which are
indicative of the physiological state of the cell. Separation of
proteins by two-dimensional gel analysis (20) separates
proteins by charge in the first dimension and by molecular
weight in the second dimension. Thus, it is possible to
discriminate among similarly sized, differently charged pro-
teins. The Coomassie blue staining pattern of a two-dimen-
sional get analysis of a cytosol prepared from cells incubated
with hormone at 0°C (Fig. 3A) showed a complex pattern of
staining, as would be predicted from the number of proteins
that are observed in Fig. LA. Fig. 3B shows the saturable
[3H]dexamethasone mesylate binding pattern typically seen
with two-dimensional gel analysis. The receptor focused as a
series of charged species, all having a molecular weight of 97
kDa and ranging in charge from a pI of 7.7 to 7.2. A gel that
was electrophoresed under the same conditions was probed
with MMTV [32P]DNA. A band of bound MMTV [32P]DNA




FIG. 3. Two-dimensional gel analysis of cytoplasmic glucocorti-
coid receptor. HeLa S3 cells were incubated with 20 nM [3H]dexa-
methasone mesylate for 2 hr, a cytosol was prepared, and samples
were treated as described. Electrophoresis in the first dimension was
by denaturing isoelectric focusing, and in the second dimension, by
NaDodSO4/PAGE. Gels were stained with Coomassie blue (A);
transferred to nitrocellulose and sprayed with EN3HANCE and
fluorographed (B); or soaked in renaturation buffer, transferred to
nitrocellulose, probed with nick-translated MMTV [32P]DNA, and
autoradiographed (C). Prestained molecular weight markers were
electrophoresed as standards (PB, phosphorylase b; BSA, bovine
serum albumin; OVAL, ovalbumin; CHY, chymotrypsinogen.
methasone mesylate seen in Fig. 3B and ranged in pI from
=7.7 to 7.2 (Fig. 3C). Comigration of the bound MMTV
[32P]DNA with the [3H]dexamethasone mesylate-labeled
band as evidenced by two-dimensional gel analysis further
suggests that the receptor protein binds MMTV [32P]DNA.
The binding buffer used in this experiment was the same as
the buffer used in the experiment shown in Fig. 1, which did
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We next investigated the ability of a purified preparation of
glucocorticoid receptor immobilized on nitrocellulose blots
to bind MMTV [32P]DNA. Glucocorticoid receptor was
partially purified as described by Wrange et al. (27). Briefly,
[3H]dexamethasone mesylate-labeled cytosol was chromato-
graphed on a phosphocellulose column followed by a DNA-
cellulose column. The eluate from the DNA-cellulose column
(containing unactivated glucocorticoid receptor) was activat-
ed by warming to 250C, reapplied to a DNA-cellulose matrix,
and eluted with 20 mM MgCl2. This fraction was then
subjected to polyacrylamide gel electrophoresis as described.
One lane of the gel was sliced and assayed for [3H]dexameth-
asone mesylate radioactivity to localize the receptor band.
The receptor was excised from an adjacent lane, soaked in
renaturation buffer, transferred to nitrocellulose, and probed
with MMTV [32P]DNA. A second nonreceptor band of
[3H]dexamethasone mesylate-binding protein at 56 kDa was
found to be nonsaturable as seen by the inability of the
tritiated label to compete with unlabeled dexamethasone
(data not shown). This band was similarly processed forDNA
binding analysis. Fig. 4 shows the autoradiographs of the two
slices from the gel. Fig. 4 Upper, representing the =97-kDa
saturable dexamethasone mesylate-binding protein, shows a
heavy band of MMTV [32P]DNA binding. In contrast, the
Fig. 4 Lower, which represents the 56-kDa nonreceptor
protein, shows no detectable DNA binding. Under the
conditions of this assay, the receptor band is nearly homo-
geneous. However, the possibility of comigrating proteins
that follow receptor purification cannot be excluded. We
consider this possibility to be unlikely. The results presented
in Fig. 4 show that the purified receptor retained the ability
to bind to MMTV [32P]DNA. In contrast, another purified
[3H]dexamethasone mesylate-labeled nonreceptor protein
did not bind the MMTV [32P]DNA. Together with the
previous observations, these findings indicate a selective
interaction between the glucocorticoid receptor and MMTV
DNA following immobilization of the receptors on nitrocel-
lulose blots.
To further substantiate the observation that MMTV
[32P]DNA was binding directly to the glucocorticoid recep-
tor, we analyzed DNA binding in cytosols of cells known to
be depleted of receptor. Previous studies (28) have shown
that the level of glucocorticoid receptors found in HeLa S3
cells is down-regulated when cells are exposed to pyridoxine.
Therefore, we tested whether cytoplasmic extracts prepared
from these cells would retain the capacity to bind MMTV
DNA. Each group of cells was analyzed for saturable nuclear
glucocorticoid receptor binding as described (24). The level
of receptor binding was significantly down-regulated (90%)
after 3 days of exposure of the cells to the B-6 vitamin (Fig.
5A). As seen previously, Fig. SB shows a 97-kDa protein
comigrating with the phosphorylase b marker, which binds
selectively to the MMTV [32P]DNA in control cells. How-
ever, no DNA binding was detected at 97 kDa in cells that
were grown in the presence of 1 mM pyridoxine. The absence
of DNA binding in cells that have been depleted of gluco-
corticoid receptors strongly suggests that the glucocor-
ticoid receptor is responsible for binding the MMTV
[32P]DNA.
These experiments provide direct evidence that the DNA-
binding domain of the nitrocellulose-immobilized human
glucocorticoid receptor can be sufficiently renatured to
recognize DNA. The question remains, however, whether
the binding site exists in a state in which it selectively
recognizes DNA containing GREs. Fig. 6 shows the results
obtained when protein blots of crude cytosol extracts con-
taining [3H]dexamethasone mesylate affinity-labeled gluco-
corticoid receptor were probed with comparably sized frag-
ments of [32P]pBR322 andMMTV [32P]DNA. The filter strips
shown were cut from adjacent lanes of the same gel contain-
ing a crude cytosol extract and, hence, differed only with
regard to the DNA fragment with which they were incubated.
The glucocorticoid receptor immobilized on nitrocellulose
filters was able to recognize and bind with high affinity to
MMTV DNA. In contrast, receptor processed under identi-
cal conditions showed only minimal binding ofpBR322 DNA.
These results suggest that glucocorticoid receptor immobi-
lized on nitrocellulose can selectively recognize and bind




















FIG. 4. Comparative analysis of [32P]DNA binding by partially
purified [3H]dexamethasone mesylate-labeled receptor and a
nonreceptor affinity-labeled protein. HeLa S3 cells were labeled with
[3H]dexamethasone mesylate as indicated and subjected to partial
purification as described. Nonabsorbed proteins representing the
glucocorticoid receptor and other non-DNA-binding proteins were
subjected to NaDodSO4/PAGE, and a lane of the gel was sliced and
assayed for radioactivity as described (13). Two protein bands, one
corresponding to the affinity-labeled glucocorticoid receptor of
molecular mass 97 kDa (Upper) and a second corresponding to a
nonreceptor protein of molecular mass 56 kDa (Lower), were
processed similarly. Each blot was then probed with MMTV





FIG. 5. The influence ofpyridoxine treatment ofHeLa S3 cells on
glucocorticoid receptor binding of steroid and MMTV [32P]DNA.
Two groups of HeLa S3 cells were grown for 3 days in control
medium or in medium supplemented with 1mM pyridoxine. Samples
from each group were processed (24) and analyzed for MMTV
[32P]DNA binding. (A) Mean ± SEM for saturable nuclear gluco-
corticoid receptor binding from three experiments. (B) Repre-
sentative MMTV [32P]DNA blot. PB, position of the phosphorylase
b marker.
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Gorski and associates (32) have been successful in renatur-
ing the steroid-binding domain of the estrogen receptor. We
have presented evidence that the DNA-binding domain ofthe
glucocorticoid receptor can be renatured so that it not only
recognizes DNA but does so in a selective manner, interact-
ing specifically with DNA containing GREs. Therefore, this
approach is of potential importance in studying GRE mutants
such as those recently developed by Hutchison et al. (33).
FIG. 6. Selective binding of isolated
[32P]DNA fragments by [3H]dexametha-
sone mesylate affinity-labeled glucocor-
ticoid receptor immobilized on nitrocel-
lulose filters. Cytosol prepared from
[3H]dexamethasone mesylate-labeled
HeLa S3 cells was processed as de-
scribed. Adjacent lanes were cut from the
resulting filter and incubated with either
the 312-bp Taq I fragment of pBR322
[32P]DNA (7.5 x 106 cpm) or the 325-bp
Hae III-Hpa II fragment of MMTV
[32P]DNA (7.5 x 106 cpm). PB, position
pBR322 MMTV of the phosphorylase b marker.
DISCUSSION
A different approach to the analysis of glucocorticoid
receptor-DNA interactions was used to obtain the results
presented here. Despite progress in the definition oftheDNA
sequences that are essential for hormonal regulation of gene
expression (1, 2, 4), knowledge of the nature of interactions
of receptors with DNA remains unclear. Major contributions
to our current understanding of receptor-DNA interactions
have come predominantly from cleavage-inhibition patterns
and methylation protection studies. These studies have
defined consensus DNA sequences with which the glucocor-
ticoid receptor associates. Glucocorticoid receptors have
been shown to bind preferentially to a number of these
consensus sequences contained in the LTR of MMTV DNA
and yield discrete cleavage-protection patterns. Although
such analyses are valuable, they often require difficult and
extensive purifications of the glucocorticoid receptor, which
may result in the selection ofparticular receptor forms. Since
our laboratory (13) and others (29) have shown that gluco-
corticoid receptors under both native and denaturing condi-
tions (C.M.S. and J.A.C., unpublished observations) display
considerable charge polymorphism, we sought to determine
if such polymorphisms in receptors are related to alterations
in receptor-DNA interactions. Such studies require the use
of crude cytoplasmic preparations and a means of identifying
the interactive proteins. To address this question, we ex-
plored the possibility that the DNA blot procedure (9, 16, 30,
31), which evaluates DNA-protein interactions, could be
applied to the glucocorticoid receptor. Several lines ofevidence
indicate the feasibility of such an approach and directly support
the conclusion that the -97-kDa protein with which the GRE
interacts is the glucocorticoid receptor. These include the
following: (i) comigration of DNA-binding activity with the
affinity-labeled receptor on one- and two-dimensional gels, (it)
appropriate subcellular distribution, (iii) the detection ofDNA
binding in purified receptor, and (iv) the absence of DNA
binding in cells that have been depleted of receptor.
The ability of the DNA-binding site of the glucocorticoid
receptor immobilized on nitrocellulose to be sufficiently
renatured to recognize DNA is strongly supported by several
criteria that are characteristic of glucocorticoid receptors.
Unlike cleavage-protection studies that utilize partially pu-
rified receptor preparations, our blotting procedure shows
that the DNA-bindng domain resides in the same peptide as
the steroid-binding portion of the molecule.
The authors thank Janet Leach and Kathy Thompson for their
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